Tag: e-mail

STOCKHOLM, Sweden, June 25, 2026 – AnaCardio, a clinical stage biopharmaceutical company developing novel drugs to treat heart failure, today announced the publication in The Lancet of results from its Phase 1b/2a GOAL-HF1 study evaluating AC01, a first-in-class, oral calcium-sensitising contractile agent, in patients with heart failure with reduced ejection fraction (HFrEF). The results showed a favourable safety and tolerability profile, dose-proportional pharmacokinetics with confirmed target engagement. In exploratory efficacy analyses, numerical rapid and sustained improvements in haemodynamics and cardiac structure and function were observed on top of optimised guideline-directed medical therapy (GDMT).

All amounts presented in this release are in U.S. Dollar (“USD”) unless otherwise stated.

NEW YORK and TORONTO, June 24, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), is pleased to announce the pricing of an underwritten offering of 10,309,280 common shares in the capital of the Company (the “Common Shares”) at an offering price of US$4.85 per Common Share, for aggregate gross proceeds of US$50 million (the “Offering”).

From 1 July 2026 Vaidas Dominauskas will lead Enterprise (B2B) unit at Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”). The manager is returning to the Company – previously he worked in various management positions at Telia Lietuva for more than 14 years, and in 2022–2025 he headed the state-owned company Regitra.

(Oslo, Norway, 22 June 2026) – Hedda Felin has been elected to the Board of Directors of Statkraft, replacing Ingelise Arntsen, who is stepping down from the Board.

Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) acquired two 1,500 MHz frequency blocks for almost EUR 10 million and stood out as the largest investor in the 1,500 MHz frequency band in an auction organized by the Communications Regulatory Authority (CRA). The Company received the largest share of these frequencies sold – 40 MHz, which will be used for further development of the 5G network. Along with this achievement, Telia Lietuva also extended the right to use the 2,100 MHz frequency band in another auction, committing to pay the state another EUR 2 million for this right.